George Lagarias, chief economist at Mazars, comments on the markets reaction to the new Covid-19 variant.
1. What is happening in markets and why?
“On Friday morning equity and bond markets reacted negatively to news that a Covid-19 variant in South Africa, now called ‘Omicron’, could inflame the pandemic, even amongst vaccinated populations. The variant contains more than 30 mutations to the spike protein, many of which are linked to increased antibody resistance. This could affect its behaviour with regard to vaccines, treatments and transmissibility. While there is evidence of increased transmissibility, which would allow it to become the dominant variant, there is no evidence as to the severity of symptoms.
“The response prompted a significant sell-off in equity markets early on Friday, with the S&P 500 losing 2.3% and European markets shedding 3.5% to 5%. Meanwhile, bond yields climbed, oil prices (which include a fair amount of speculation) fell by 6%, and gold gained 1%. This is a classic ‘risk-off’ episode, the worst in about thirteen months.
2. Did the markets overreact?
“At this point, it’s difficult to say. While the variant is probably more transmissible, it will take a few weeks to determine whether it bypasses vaccination or leads to more severe illness, and what its impact might be to younger populations.
“There is evidence to suggest that we should wait before calling for a major correction.
- “The risk-off event happened on the Friday after Thanksgiving, when the US market (and many European trading desks) worked on skeleton crews, so trading volumes were probably lower than usual.
- “The selloff took place at the end of the US earnings season and the closure of books for hedge funds and prop desks. Central banks are turning more hawkish on inflation concerns, and just a couple of days ago the Fed said it might speed up the timetable for ending this round of asset purchases. Global stocks had already gained almost 21% year-on-year, and even if the event hadn’t happened, it would not have been the worst time for market participants to take some profit off the table.
- “Liquidity is ample, more than it has never been. The next few days, or maybe weeks, will show whether investors will take advantage of lower valuations to put their money to work or whether they will continue with the selloff.
“Needless to say that the market response will be closely monitored by policymakers.
3. Will this affect the economic recovery?
“The course of the pandemic in 2022 is not expected to be linear. By and large the pandemic continues to determine economic output and supply chain cohesion. Already the Delta variant, was potent enough to prompt a sharp upgrade in stringency measures in Germany, Austria and Italy (68%, 65% and 73% full vaccination rates respectively), with other countries sure to follow. An even more transmissible variant, even if completely covered by current vaccines, could materially increase pressures on consumers, businesses and supply chains, unless infection symptoms are much more mild.
“On the other hand, 2022 is not 2020. Countries are better prepared and have mechanisms in place to stop and track infections. Some have already taken measures to protect against the Delta variant, so the spread of Omicron could be contained. Along with vaccines, which can be upgraded, Merck and Pfizer are preparing to circulate pills to treat Covid early in 2022. From a business perspective, hybrid working has allowed for many activities to go uninterrupted. As a society, we have learned to live with this virus.
“Having said that, further pressure on already weary and misfunctioning supply chains could have a significant impact on economic activity and inflation, making this an even harder winter. Another, more vaccine resistant variant will push the recovery further into 2023, but its impact would have to be devastating to take us back to square one.